A Pilot Randomised Control Trial to determine the acceptability and feasibility of providing early intervention with the Omo Neurexa shoulder Orthoses when compared to usual practice, in reducing the development of Hemiplegic shoulder pain post stroke.
Not Applicable
- Conditions
- StokeShoulder painStroke - HaemorrhagicMusculoskeletal - Other muscular and skeletal disordersStroke - Ischaemic
- Registration Number
- ACTRN12619000068167
- Lead Sponsor
- epean Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Stopped early
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
First Cardiovascular Accident
Hemiparetic upper limb - manual muscle testing below 3/5 and unable to hold the shoulder at 90 degrees forward flexion for < 10 seconds.
No premorbid shoulder issues
Exclusion Criteria
Language or Cognitive deficits precluding the participant from being able to provide informed consent or self report on pain levels or issues with either device.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Composite outcome - Acceptability will be evaluated by the percentage of participants who, (1) agreed to participate, (2) complied with wearing the support for the allotted time period per day (3) attended the follow up assessments. This will be recorded in two ways (1) self-report using a questionnaire at the assessment intervals - see below. (2) study records[12 weeks post enrolment, assessed at 4 weekly intervals for 12 weeks post enrolment<br>];Composite outcome - Feasibility will be evaluated by (1) number of patients who met the inclusion criteria, (2) number of participants recruited from the total number screened, (3) Number of drop outs. This will be recorded via the study screening forms, consent forms and study records. [12 weeks post enrolment, assessed at 4 weekly intervals for 12 weeks post enrolment];Composite outcome - Delays in initial transfer out of bed and compliance of nursing staff applying the supports will be evaluated via a medical record review.[ 12 weeks post enrolment]
- Secondary Outcome Measures
Name Time Method